-
61
-
62
-
63
2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years).
Baskı/Yayın Bilgisi 2025Konular: -
64
Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black).
Baskı/Yayın Bilgisi 2025Konular: -
65
-
66
Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64).
Baskı/Yayın Bilgisi 2025Konular: -
67
Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx
Baskı/Yayın Bilgisi 2025Konular: -
68
Discovery and Characterization of Novel BLIMP‑1 Heterobifunctional Ligand-Directed Degraders
Baskı/Yayın Bilgisi 2025Konular: -
69
Data Sheet 1_Molecular mechanisms of TTC21B gene mutations in nephronophthisis type 12 and genetic prevention through PGT.docx
Baskı/Yayın Bilgisi 2025Konular: -
70
Table 1_IgA expressed by glomerular mesangial cells is involved in the pathogenesis of IgA nephropathy.docx
Baskı/Yayın Bilgisi 2025Konular: -
71
Asymmetric Total Synthesis and Anti-Inflammatory Activity of Berbamine, Oxyacanthine, and Related Intermediates
Baskı/Yayın Bilgisi 2025Konular: -
72
Filamin A KO or S2152A KI does not affect KSHV lytic reactivation.
Baskı/Yayın Bilgisi 2025Konular: -
73
Filamin A phosphorylation is essential for ORF45-induced detachment and migration but not for virion production.
Baskı/Yayın Bilgisi 2025Konular: -
74
Filamin A KO and S2152A KI in donor cells do not affect KSHV cell-to-cell viral transmission.
Baskı/Yayın Bilgisi 2025Konular: -
75
-
76
Validation of Filamin A KO and S2152A KI stable HEK293-mcherry cells.
Baskı/Yayın Bilgisi 2025Konular: -
77
-
78
Filamin A KO and S2152A KI reduce KSHV de novo infection and cell-contact mediated viral infection.
Baskı/Yayın Bilgisi 2025Konular: -
79
Filamin A KO and S2152A KI reduce KSHV de novo infection of cell-free virions.
Baskı/Yayın Bilgisi 2025Konular: -
80
The treatment of RSK inhibitors attenuates ORF45-increased ability of cell migration.
Baskı/Yayın Bilgisi 2025Konular: